{"pmid":32473354,"title":"Racial disparity in Covid-19 mortality rates - A plausible explanation.","text":["Racial disparity in Covid-19 mortality rates - A plausible explanation.","Clin Immunol","Tal, Yuval","Adini, Avner","Eran, Alal","Adini, Irit","32473354"],"journal":"Clin Immunol","authors":["Tal, Yuval","Adini, Avner","Eran, Alal","Adini, Irit"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32473354","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.clim.2020.108481","topics":["Mechanism","Treatment"],"weight":1,"_version_":1668255193390645248,"score":9.490897,"similar":[{"pmid":32389591,"title":"Air pollution, racial disparities and COVID-19 mortality.","text":["Air pollution, racial disparities and COVID-19 mortality.","J Allergy Clin Immunol","Brandt, Eric B","Beck, Andrew F","Mersha, Tesfaye B","32389591"],"journal":"J Allergy Clin Immunol","authors":["Brandt, Eric B","Beck, Andrew F","Mersha, Tesfaye B"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32389591","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.jaci.2020.04.035","keywords":["african american","covid-19","no(2)","pm2.5","sars-cov-2","air pollution","coronavirus","minorities","racial disparity"],"weight":0,"_version_":1666528580137385986,"score":57.18279},{"pmid":32305444,"pmcid":"PMC7162783","title":"COVID-19 and Racial Disparities.","text":["COVID-19 and Racial Disparities.","J Am Acad Dermatol","Shah, Monica","Sachdeva, Muskaan","Dodiuk-Gad, Roni P","32305444"],"journal":"J Am Acad Dermatol","authors":["Shah, Monica","Sachdeva, Muskaan","Dodiuk-Gad, Roni P"],"date":"2020-04-20T11:00:00Z","year":2020,"_id":"32305444","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jaad.2020.04.046","keywords":["covid-19","coronavirus","epidemiology","ethnicity","race","racial disparities"],"weight":0,"_version_":1666138493381771265,"score":55.165245},{"pmid":32391864,"title":"COVID-19 and Racial/Ethnic Disparities.","text":["COVID-19 and Racial/Ethnic Disparities.","JAMA","Webb Hooper, Monica","Napoles, Anna Maria","Perez-Stable, Eliseo J","32391864"],"journal":"JAMA","authors":["Webb Hooper, Monica","Napoles, Anna Maria","Perez-Stable, Eliseo J"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32391864","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1001/jama.2020.8598","weight":0,"_version_":1666528580040916993,"score":51.804684},{"pmid":32361588,"pmcid":"PMC7195103","title":"Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19.","text":["Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19.","Corona virus disease 2019 (COVID-19) pandemic caused 18 440 deaths world wide as of 25 March 2020 and posing a serious threat to public health. There is a need, therefore, for effective therapeutic strategies to cure this disease. However, high attrition rates, substantial costs and slow pace are the major limitations of novel drug discovery. Drug repurposing, by employing 'old' drugs to treat 'new' diseases is an attractive approach in drug discovery. Niclosamide (NIC) is an approved anti-helminthic drug with diverse antiviral mechanisms. In this work we hypothesize, the potential antiviral mechanisms of NIC against COVID-19.","Med Hypotheses","Pindiprolu, Sai Kiran S S","Pindiprolu, Sai Harshini","32361588"],"abstract":["Corona virus disease 2019 (COVID-19) pandemic caused 18 440 deaths world wide as of 25 March 2020 and posing a serious threat to public health. There is a need, therefore, for effective therapeutic strategies to cure this disease. However, high attrition rates, substantial costs and slow pace are the major limitations of novel drug discovery. Drug repurposing, by employing 'old' drugs to treat 'new' diseases is an attractive approach in drug discovery. Niclosamide (NIC) is an approved anti-helminthic drug with diverse antiviral mechanisms. In this work we hypothesize, the potential antiviral mechanisms of NIC against COVID-19."],"journal":"Med Hypotheses","authors":["Pindiprolu, Sai Kiran S S","Pindiprolu, Sai Harshini"],"date":"2020-05-04T11:00:00Z","year":2020,"_id":"32361588","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.mehy.2020.109765","keywords":["covid-19","drug discovery","niclosamide","repurposing","sars-cov-2"],"e_drugs":["Niclosamide"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138495525060608,"score":47.984478},{"pmid":32374952,"title":"Racial Health Disparities and Covid-19 - Caution and Context.","text":["Racial Health Disparities and Covid-19 - Caution and Context.","N Engl J Med","Chowkwanyun, Merlin","Reed, Adolph L Jr","32374952"],"journal":"N Engl J Med","authors":["Chowkwanyun, Merlin","Reed, Adolph L Jr"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32374952","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1056/NEJMp2012910","topics":["General Info"],"weight":1,"_version_":1666138496359727104,"score":46.178474}]}